Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry
Tigecycline is the first of a new class of antibiotics named glycylcyclines and it was approved for the treatment of complicated intra-abdominal infections and complicated skin and skin structure infections. Notwithstanding this, tigecycline's pharmacological and microbiological profile which includes multidrug-resistant pathogens encourages physicians' use of the drug in other infections. We analyzed, during the first months after its launch, the tigecycline prescriptions for 113 patients in 12 institutions. Twenty-five patients (22%) received tigecycline for approved indications, and 88 (78%) for "off label" indications (56% with scientific support and 22% with limited or without any scientific support). The most frequent "off label" use was ventilator associated pneumonia (VAP) (63 patients). The etiology of infections was established in 105 patients (93%). MDR-Acinetobacter spp. was the microorganism most frequently isolated (50% of the cases). Overall, attending physicians reported clinical success in 86 of the 113 patients (76%). Our study shows that the "off label" use of tigecycline is frequent, especially in VAP. due to MDR-Acinetobacter spp., where the therapeutic options are limited (eg: colistin). Physicians must evaluate the benefits/risks of using this antibiotic for indications that lack rigorous scientific support.
Main Authors: | Curcio,Daniel, Fernández,Francisco, Cané,Alejandro, Barcelona,Laura, Stamboulian,Daniel |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Brazilian Society of Infectious Diseases
2008
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000300007 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of tigecycline and its role in the era of antibiotic resistance
by: Rossi,Flávia, et al.
Published: (2006) -
Rates of antimicrobial resistance in latin america (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics
by: Rossi,Flávia, et al.
Published: (2008) -
A comparative analysis between survivors and nonsurvivors patients treated with tigecycline
by: Curcio,Daniel
Published: (2013) -
Guideline: appropriate use of tigecycline
by: Brink,A J, et al.
Published: (2010) -
Guideline summary: Appropriate use of tigecycline
by: Brink,A. J., et al.
Published: (2012)